- Home
- SABR vs BVS Comparison
SABR vs BVS Comparison
Compare SABR & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SABR | BVS |
|---|---|---|
| Founded | 2006 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 814.3M | 716.8M |
| IPO Year | 2014 | 2016 |
Fundamental Metrics
Financial Performance| Metric | SABR | BVS |
|---|---|---|
| Price | $1.53 | $9.29 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $1.50 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 5.6M | 460.6K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 283.56 | 163.46 |
| EPS | 0.02 | ★ 0.04 |
| Revenue | ★ $3,866,956,000.00 | $568,087,000.00 |
| Revenue This Year | $7.51 | $7.52 |
| Revenue Next Year | $3.46 | $7.06 |
| P/E Ratio | ★ $77.75 | $238.50 |
| Revenue Growth | ★ 7.46 | N/A |
| 52 Week Low | $0.81 | $5.81 |
| 52 Week High | $3.46 | $11.25 |
Technical Indicators
Market Signals| Indicator | SABR | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 39.22 | 38.74 |
| Support Level | $1.49 | $8.13 |
| Resistance Level | $1.61 | $11.00 |
| Average True Range (ATR) | 0.14 | 0.65 |
| MACD | -0.05 | -0.14 |
| Stochastic Oscillator | 6.16 | 5.33 |
Price Performance
Historical ComparisonAbout SABR Sabre Corporation
Sabre holds the number-two air booking volume share in the global distribution system industry. The distribution segment represented 80% of total 2025 revenue and airline IT solutions 20% of revenue. The company sold its growing hotel IT solutions division to TPG in 2025 for $960 million in net proceeds. Transaction fees, which are mostly tied to volume and not price, account for the bulk of sales and profits.
About BVS Bioventus Inc.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.